[Asia Economy Reporter Lim Chunhan] FutureChem announced on the 21st that it confirmed the safety and efficacy of the prostate cancer treatment candidate substance 'FC705' in the domestic Phase 1 clinical trial results.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
